All In MedTech

Device Trial Radar · NCT01494454

Clinical Study of rhBMP-2/BCP With the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease

A Clinical Study of Recombinant Human Bone Morphogenetic Protein-2 and Biphasic Calcium Phosphate With Either the TSRH® Spinal System or the CD Horizon® Spinal System for Posterolateral Lumbar Fusion in Patients With DDD

Last checked: Nov 19, 2026Latest source record: May 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 197 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

197

Actual

Start

Aug 1999

Primary completion

Nov 2007

Study completion Nov 2007

Sponsor

Lead sponsor
Medtronic Spinal and BiologicsPublic (MDT)
Sponsor type
Industry
First posted
Dec 19, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to assess the safety and effectiveness of the rhBMP/BCP/TRSH Spinal System in treatment of the patients with degenerative disc disease.

Conditions

  • Degenerative Disc Disease

Interventions

  • rhBMP-2/BCP/TSRH® or rhBMP-2/BCP/CD HORIZON® Spinal SystemDevice

    rhBMP-2/BCP device will be used in conjunction with the posterior spinal fixation system, either the TSRH® Spinal System or CD HORIZON® Spinal System.

  • Autograft/TSRH® or autograft/CD HORIZON® Spinal System.Device

    Either the TSRH® Spinal System or the CD HORIZON® Spinal System with autogenous bone taken from the patient's iliac crest.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. FusionTime frame: 24 month
  2. Pain/Disability StatusTime frame: 24 month

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.